Clinical trial
Effects of Carboplatin and Gemcitabine on Stage IIIB Pleural Effusion and Stage…
NCT00247416 · Susanne Arnold, Other · Completed
Key facts
| NCT number | NCT00247416 |
|---|---|
| Title | Effects of Carboplatin and Gemcitabine on Stage IIIB Pleural Effusion and Stage IV Lung Cancer |
| Official title | Randomized Phase II Trail of Carboplatin and Gemcitabine Untreated Stage IIIB-pleural Effusion and Stage IV Lung Cancer |
| Lead sponsor | Susanne Arnold, Other |
| Collaborators | Kentucky Lung Cancer Research Program |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Stage IV Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer |
| Intervention type | Drug |
| Interventions | Gemcitabine, Dexamethasone, Carboplatin |
| Enrollment | 60 |
| Start date | Aug 1, 2005 |
| Primary completion | Jul 1, 2009 |
| Completion | Jul 1, 2009 |
| First posted | Nov 1, 2005 |
| Last update posted | Mar 7, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: